On the evening of March 26, Daon shares (002838) released the first quarter performance forecast for 2019. It is expected to achieve a net profit of 3,246,800 yuan to 3,996,600 yuan in the first quarter, an increase of 30% to 60%.
For reasons of performance growth, Daun shares said that due to the company's internal efforts to strengthen cost control, increase sales revenue, improve production efficiency, and the consolidation of Haier's new materials, the net profit of the returning home has achieved steady growth.
At the same time, the company announced that the special hydrogenated nitrile rubber project constructed by Shandong Daun Special Elastomer Co., Ltd., a wholly-owned subsidiary, meets the trial production requirements and will undergo trial production.
According to the previously announced announcement, the hydrogenated nitrile rubber (HNBR) project has an investment of 110 million yuan. After the completion of the construction, the production capacity will reach 3,000 tons/year, and the annual production capacity of the first phase will be 1,000 tons/year.
"At present, the industrial products of HNBR in the world are only Germany Bayer and Japan's Rui Weng." According to the relevant person of Daon, the company has developed a new hydrogenation catalyst with good hydrogenation activity, high selectivity and hydrogenation of the catalyst. The activity has reached the level of international similar products, and the cost is relatively low, mainly used in aerospace, automotive, petroleum and other fields, such as aerospace seals, fuel system components, automotive oil seals, automotive transmission belts, drilling holding boxes and mud. Pistons, shock absorbing materials, etc.
According to public information, Daon's hydrogenated nitrile rubber project is not only a key construction project in Yantai, but also a strategic industry supported by China Manufacturing 2025. It belongs to national strategic materials and is the most promising new material variety. one.
It is reported that the company also undertakes the research and development and industrialization of thermoplastic medical brominated butyl rubber and tire new gas barrier layer materials. After completion, it can break the monopoly of foreign companies' technology and market and realize domestic substitution.
In addition, Daun shares also announced that the company plans to set up a wholly-owned subsidiary in Beijing with its own funds of 10 million yuan. "The establishment of a wholly-owned subsidiary is to further strengthen the strength of the Beijing Technology R&D Center, expand overseas operations and promotion, and carry out the business of foreign investment and external cooperation related to thermoplastic elastomers," said Daun.
The company said that the trial production of HNBR project and the establishment of a wholly-owned subsidiary in Beijing will help increase the company's new economic growth point, further adjust the company's industrial development layout, expand the company's business scope, enhance the company's comprehensive competitiveness and overall profitability, and implement The company "strives to become the world's leading, most competitive elastomer new materials company" strategic planning.
